Dendritic Cell Vaccine for Children and Adults With Sarcoma
Status:
Active, not recruiting
Trial end date:
2024-07-23
Target enrollment:
Participant gender:
Summary
The purpose if this study is to evaluate an investigational vaccine using patient-derived
dendritic cells (DC), a type of white blood cell that helps fight infections in the body,
(DC) (a vaccine made out of participants' own cells and tumor) to treat sarcoma.